1. Home
  2. NMRA vs PLAB Comparison

NMRA vs PLAB Comparison

Compare NMRA & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • PLAB
  • Stock Information
  • Founded
  • NMRA 2019
  • PLAB 1969
  • Country
  • NMRA United States
  • PLAB United States
  • Employees
  • NMRA N/A
  • PLAB N/A
  • Industry
  • NMRA
  • PLAB Semiconductors
  • Sector
  • NMRA
  • PLAB Technology
  • Exchange
  • NMRA Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • NMRA 1.7B
  • PLAB 1.6B
  • IPO Year
  • NMRA 2023
  • PLAB 1987
  • Fundamental
  • Price
  • NMRA $2.05
  • PLAB $24.57
  • Analyst Decision
  • NMRA Strong Buy
  • PLAB Strong Buy
  • Analyst Count
  • NMRA 6
  • PLAB 1
  • Target Price
  • NMRA $20.67
  • PLAB $35.00
  • AVG Volume (30 Days)
  • NMRA 6.3M
  • PLAB 580.8K
  • Earning Date
  • NMRA 03-06-2025
  • PLAB 02-19-2025
  • Dividend Yield
  • NMRA N/A
  • PLAB N/A
  • EPS Growth
  • NMRA N/A
  • PLAB 2.96
  • EPS
  • NMRA N/A
  • PLAB 2.09
  • Revenue
  • NMRA N/A
  • PLAB $866,946,000.00
  • Revenue This Year
  • NMRA N/A
  • PLAB $7.65
  • Revenue Next Year
  • NMRA N/A
  • PLAB $7.10
  • P/E Ratio
  • NMRA N/A
  • PLAB $11.76
  • Revenue Growth
  • NMRA N/A
  • PLAB N/A
  • 52 Week Low
  • NMRA $1.83
  • PLAB $20.25
  • 52 Week High
  • NMRA $21.00
  • PLAB $34.16
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 20.26
  • PLAB 52.22
  • Support Level
  • NMRA $2.12
  • PLAB $22.95
  • Resistance Level
  • NMRA $2.44
  • PLAB $25.36
  • Average True Range (ATR)
  • NMRA 0.39
  • PLAB 0.66
  • MACD
  • NMRA -0.31
  • PLAB 0.04
  • Stochastic Oscillator
  • NMRA 2.26
  • PLAB 67.22

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: